Gain Therapeutics Inc (GANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GANX | CSBR | NRXP | ||
| Company | Gain Therapeutics Inc | Champions Oncolog | Nrx Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.9500 | 5.70 | 2.15 | ||
| High | 2.0300 | 5.98 | 2.24 | ||
| Low | 1.8900 | 5.70 | 2.15 | ||
| Latest | 1.9400 | 5.91 | 2.16 | ||
| Change | unch | +0.16 | +0.03 | ||
| % Change | unch | +2.87% | +1.41% | ||
| Volume | 574,700 | 7,100 | 417,600 | ||
| 20-Day Average Volume | 852,575 | 10,020 | 857,075 | ||
| Previous Close | 1.9400 | 5.75 | 2.13 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.2695 | 5.91 | 1.97 | ||
| 20-Day Raw Stochastic | 15.67% | 49.40% | 62.07% | ||
| 20-Day Relative Strength | 44.24 | 47.28 | 54.27 | ||
| Weighted Alpha | -12.06 | -13.73 | +2.80 | ||
| Today's Opinion | 56% Sell | 88% Sell | 24% Sell | ||
| Previous Opinion | 56% Sell | 100% Sell | 48% Sell | ||
| Last Month's Opinion | 40% Buy | 80% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.02% since 03/25/26 | +1.98% since 03/25/26 | -10.37% since 03/25/26 | ||
| Low | 1.7300 on 03/30/26 | 5.65 on 03/27/26 | 2.06 on 03/30/26 | ||
| High | 2.0700 on 03/26/26 | 5.98 on 04/01/26 | 2.43 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | -25.67% since 02/27/26 | -0.67% since 02/27/26 | +16.13% since 02/27/26 | ||
| Low | 1.7300 on 03/30/26 | 5.50 on 03/13/26 | 1.62 on 03/09/26 | ||
| High | 3.0699 on 03/06/26 | 6.34 on 03/17/26 | 2.49 on 03/25/26 | ||
| 3-Month | |||||
| %Chg | -39.75% since 12/31/25 | -14.40% since 12/31/25 | -20.30% since 12/31/25 | ||
| Low | 1.6100 on 02/05/26 | 5.50 on 03/13/26 | 1.62 on 03/09/26 | ||
| High | 3.2900 on 01/02/26 | 7.71 on 01/28/26 | 2.77 on 01/02/26 | ||
| 6-Month | |||||
| %Chg | +6.59% since 10/01/25 | -7.58% since 10/01/25 | -35.33% since 10/01/25 | ||
| Low | 1.6100 on 02/05/26 | 5.50 on 03/13/26 | 1.62 on 03/09/26 | ||
| High | 4.3400 on 12/11/25 | 8.31 on 12/15/25 | 3.84 on 10/07/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 81,949 | 82,142 | 71,427 | ||
| Shares Outstanding, K | 42,242 | 13,887 | 33,068 | ||
| Annual Sales | 0 | 56,940,000 | 1,230,000 | ||
| Annual Net Income | -20,160,000 | 4,700,000 | -28,620,000 | ||
| Last Quarter Sales | 0 | 16,560,000 | 980,000 | ||
| Last Quarter Net Income | -4,540,000 | -280,000 | 360,000 | ||
| 60-Month Beta | 0.11 | 0.40 | 1.83 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 03/26/26 | -0.02 on 03/12/26 | 0.19 on 03/23/26 | ||
| Latest Earnings Date | 05/13/26 | 07/22/26 | 05/21/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||